CHR. OLESEN SYNTHESIS A/S
CVR 33964870 · Public limited company (A/S) · Active · Medium risk
CHR. OLESEN SYNTHESIS A/S is a Public limited company (A/S), founded on , based in Hvidovre. The company is registered in the industry fremstilling af farmaceutiske råvarer. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 14 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -9.5m and a net result of DKK -2.3m.
Bankruptcy risk for CHR. OLESEN SYNTHESIS A/S
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 33964870
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (15 years)
- Address
- Kanalholmen 8
2650 Hvidovre - Municipality
- Hvidovre
- Industry
- Fremstilling af farmaceutiske råvarer (211000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 568k
- Employees
- 46 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 14 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -38.9% |
| Current ratio | 173% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 7.0m | DKK 10.6m |
| Net profit | DKK -2.3m | DKK 7.4m |
| Equity | DKK -9.5m | DKK -7.2m |
| Total assets | DKK 24.4m | DKK 22.0m |
| Short-term debt | DKK 9.3m | – |
| Tax owed | DKK 0 | – |
| Avg. employees | 79 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 103 | ||
| 1 Jan 2024 – 31 Dec 2024 | 118 | ||
| 1 Jan 2023 – 31 Dec 2023 | 108 | ||
| 1 Jan 2022 – 31 Dec 2022 | 89 | ||
| 1 Jan 2021 – 31 Dec 2021 | 145 | ||
| 1 Jan 2020 – 31 Dec 2020 | 118 | ||
| 1 Jan 2019 – 31 Dec 2019 | 92 | ||
| 1 Oct 2017 – 30 Sep 2018 | 82 | ||
| 1 Oct 2016 – 30 Sep 2017 | 100 | ||
| 1 Oct 2015 – 30 Sep 2016 | 131 | ||
| 1 Oct 2014 – 30 Sep 2015 | 134 | ||
| 1 Oct 2013 – 30 Sep 2014 | 149 | ||
| 1 Oct 2012 – 30 Sep 2013 | 150 | ||
| 17 Oct 2011 – 30 Sep 2012 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Terje Aarbogh | ||
| CEO | Svend Aage Johansen | ||
| CEO | Terje Aarbogh | ||
| Board | Thomas Michael Moestrup | Current | |
| Board | Joseph Nivaro | Current | |
| Board | Jean-Francois Hilaire | Current | |
| Board | Svend Aage Johansen | ||
| Board | Allan Ardensø | ||
| Board | Mads Christian Olesen | ||
| Board | Terje Aarbogh | ||
| Board | James Charles Gale | ||
| Board | Tibor Simon | ||
| Board | Jørgen Damsbo Andersen | ||
| Owner (100%) | Samfara/Bidco Limited | Current | |
| Owner (25%) | CHRISJOPALI ApS | ||
| Owner (50%) | CHR. OLESEN A/S | ||
| Owner (15%) | AARBOGH BUSINESS PARTNER HOLDING ApS | ||
| Owner (50%) | CHR. OLESEN A/S | ||
| Owner (5%) | Signet Healthcare Partners Accredited Partnership III,LP | ||
| Owner (33%) | Signet Healthcare Partners QP Partnership III, LP | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | CHR. OLESEN PHARMACEUTICALS A/S | Current |
The CEOs' other companies
Terje Aarbogh – 3 other companies
- AARBOGH BUSINESS PARTNER HOLDING ApS Active
- CHR. OLESEN PHARMACEUTICALS A/S Active
- XELLIA PHARMACEUTICALS ApS Active
Svend Aage Johansen – 17 other companies
- ANESTIC ApS Compulsorily dissolved
- Atnahs Pharma Denmark ApS Active
- BECKETT INVEST ApS Compulsorily dissolved
- BIO RESEARCH A/S Opløst
- CCURE A/S Active
- CHR. OLESEN PHARMACEUTICALS A/S Active
- DLI - DANSK LÆGEMIDDEL INFORMATION A/S Active
- ETHNOCINE ApS Opløst
- INFORMEDICA A/S Compulsorily dissolved
- MEDIC TEAM A/S Fusioneret
- MEDICAL MATCH A/S Active
- MERCK A/S Opløst
- NM AF 18. JUNI 2009 A/S Active
- NORDMEDICA A/S Active
- Pharmanovia A/S Active
- TPR-GROUP ApS Active
- Øresund Pharma ApS Active
Address history (4 moves)
| Kanalholmen 8, 2650 Hvidovre | |
| Kanalholmen 8, 2650 Hvidovre | |
| Jægersborg Alle 164, 2820 Gentofte | |
| Kanalholmen 8, 2650 Hvidovre | |
| Jægersborg Alle 164, 2820 Gentofte |
Employees per year
Other companies at the same address
- PHARMAZELL A/S Bankrupt
- PHARMAZELL DENMARK A/S Bankrupt
- BIOCUR A/S Fusioneret
- HEXAL A/S Fusioneret
- HEXAL SCANDINAVIA A/S Fusioneret
Similar companies in Hvidovre
- PHARMAZELL DENMARK A/S Hvidovre
- PHARMAZELL A/S Hvidovre
Questions and answers about CHR. OLESEN SYNTHESIS A/S
Has CHR. OLESEN SYNTHESIS A/S gone bankrupt?
No, CHR. OLESEN SYNTHESIS A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of CHR. OLESEN SYNTHESIS A/S?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the auditor of CHR. OLESEN SYNTHESIS A/S?
CHR. OLESEN SYNTHESIS A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was CHR. OLESEN SYNTHESIS A/S founded?
CHR. OLESEN SYNTHESIS A/S was founded on 17 October 2011.
What is the equity of CHR. OLESEN SYNTHESIS A/S?
Equity was DKK -9.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.